The investment objective is to generate long term capital appreciation by investing in equity and equity related instruments including equity derivatives & International Stocks, debt, money market instruments.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| Dynamic Asset Allocation | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -1.79% | 3.05% | 6.74% | 1.48% | -6.23% | -7.59% | 0.98% | 5.34% | 3.94% | 6.61% | 6.64% |
| Category returns | -1.99% | -2.32% | -0.59% | -1.87% | -2.97% | -0.89% | 6.58% | 7.41% | 5.44% | 7.73% | N/A |
| Absolute returns | -1.79% | 3.05% | 6.74% | 1.48% | -6.23% | -14.62% | 2.96% | 23.15% | 21.34% | 89.66% | 91.01% |
| Rank within category | 7/16 | 1/16 | 1/16 | 3/16 | 15/16 | 15/15 | 12/12 | 9/10 | 7/8 | 5/6 | N/A |
| Dynamic Asset Allocation | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yearly returns | N/A | 24.39% | -0.84% | 10.9% | 8.8% | 7.41% | -1.11% | 24.1% | 9.37% | -7.15% | -0.76% |
| Q1 returns | N/A | 11.28% | 0.06% | 2.72% | -14.39% | 1.72% | -3.02% | -4.55% | 2.01% | -13.55% | -12.85% |
| Q2 returns | N/A | 4.62% | -0.03% | 1.92% | 12.26% | 2.23% | -6.56% | 13.76% | 8.04% | 8.6% | 10.09% |
| Q3 returns | N/A | 3.34% | -2.43% | 2.6% | 5.35% | 3.98% | 10.63% | 12.17% | 9.89% | -2.09% | 4.02% |
| Q4 returns | -2.85% | 3.4% | 1.59% | 3.24% | 7.47% | -0.67% | -1.35% | 1.89% | -9.71% | 1.01% | -0.57% |
1% on or before 365D, Nil after 365D
| Alpha | -0.311372 |
| Beta | 0.7436 |
| Sharpe Ratio | -0.0642541 |
| Sortino Ratio | -0.104572 |
| R-Squared | 0.4468 |
| Tracking Error | 3.109 |
| Downside Risk | 23.6936 |
| Std. Deviation (Annualised) | 13.8427 |
| Dynamic Asset Allocation | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quant Dynamic Asset Allocation Fund - Regular Plan - Growth | -3.55% | -5.72% | -2.05% | -1.01% | -5.15% | 10.55% | N/A | N/A | 13.73% | 810.16 | 3.04 | 0.11 | Very High |
| Edelweiss Balanced Advantage Fund - Regular Plan - Growth | -1.93% | -1.48% | -0.27% | -0.61% | -0.31% | 8.77% | 7.12% | 10.41% | 10.05% | 12,880.20 | 1.92 | 0.10 | Very High |
| DSP Dynamic Asset Allocation Fund - Regular Plan - Growth | -1.78% | -3.01% | -0.97% | -0.94% | -0.11% | 8.56% | 6.87% | 7.76% | 8.45% | 3,703.78 | 2.26 | 0.11 | Very High |
| Mirae Asset Balanced Advantage Fund - Regular Plan - Growth | -1.87% | -2.1% | -0.69% | -0.77% | 0.11% | 8.26% | N/A | N/A | 8.99% | 2,109.29 | 2.28 | 0.09 | Very High |
| Invesco India Balanced Advantage Fund - Regular Plan - Growth | -0.13% | -1.56% | -0.46% | -4.14% | -4.98% | 7.21% | 6.61% | 8.3% | 9.03% | 903.03 | 2.40 | 0.04 | Very High |
| Franklin India Balanced Advantage Fund - Regular Plan - Growth | -3.74% | -4.31% | -3.31% | -3.92% | -4.84% | 6.96% | N/A | N/A | 8.25% | 2,686.76 | 2.22 | 0.05 | Very High |
| UTI Unit Linked Insurance Plan | -1.52% | -1.37% | 2.39% | 0.41% | -1.54% | 6.69% | 4.57% | 6.82% | 10.44% | 4,930.11 | 1.60 | 0.03 | High |
| UTI Balanced Advantage Fund - Regular Plan - Growth | -1.15% | -2.89% | -2.07% | -5.28% | -5.2% | 6.44% | N/A | N/A | 6.51% | 2,855.76 | 2.01 | 0.01 | Very High |
| Sundaram Dynamic Asset Allocation Fund - Growth | -3.98% | -4.12% | -3.43% | -5.21% | -6.1% | 5.8% | 5.76% | 6.46% | 7.97% | 1,596.06 | 2.53 | 0.02 | High |
| Motilal Oswal Balanced Advantage Fund - Regular Plan - Growth Current | -1.79% | 3.05% | 6.74% | 1.48% | -6.23% | 0.98% | 3.94% | 6.61% | 6.64% | 711.71 | 2.84 | -0.06 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Triparty Repo | Cash & Cash Equivalents and Net Assets | 8.79% | |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | 5.44% | |
| Kotak Mahindra Bank Ltd. | Banks | Domestic Equities | 4.35% |
| Coforge Ltd. | IT - Software | Domestic Equities | 4.06% |
| Eternal Ltd. | Retailing | Domestic Equities | 3.55% |
| ICICI Prudential Asset Management Company Ltd. | Capital Markets | Domestic Equities | 3.51% |
| 7.3763% Bajaj Finance Limited 2028 ** | Corporate Debt | 3.47% | |
| 7.4091% HDB Financial Services Limited 2028 ** | Corporate Debt | 3.47% | |
| 7.1554% Kotak Mahindra Prime Limited 2028 ** | Corporate Debt | 3.46% | |
| Axis Bank Ltd. | Banks | Domestic Equities | 3.45% |
| 7.88% Muthoot Finance Limited 2028 ** | Corporate Debt | 3.45% | |
| 7.12% Tata Capital Limited 2028 ** | Corporate Debt | 3.44% | |
| Diamond Power Infrastructure Ltd. | Electrical Equipment | Domestic Equities | 3.29% |
| Lenskart Solutions Ltd. | Retailing | Domestic Equities | 3.28% |
| IndusInd Bank Ltd. | Banks | Domestic Equities | 3.20% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.15% |
| Shaily Engineering Plastics Ltd. | Consumer Durables | Domestic Equities | 2.95% |
| Kusumgar Ltd. | Textiles & Apparels | Domestic Equities | 2.93% |
| Larsen & Toubro Ltd. | Construction | Domestic Equities | 2.80% |
| Varun Beverages Ltd. | Beverages | Domestic Equities | 2.72% |
| Kanohar Electricals Ltd. | Electrical Equipment | Domestic Equities | 2.67% |
| United Spirits Ltd. | Beverages | Domestic Equities | 2.51% |
| LG Electronics India Ltd. | Consumer Durables | Domestic Equities | 2.46% |
| ABB India Ltd. | Electrical Equipment | Domestic Equities | 2.13% |
| Billionbrains Garage Ventures Ltd. | Capital Markets | Domestic Equities | 2.11% |
| Titan Company Ltd. | Consumer Durables | Domestic Equities | 2.10% |
| Shriram Finance Ltd. | Finance | Domestic Equities | 1.82% |
| Samvardhana Motherson International Ltd. | Auto Components | Domestic Equities | 1.69% |
| Jindal Steel Ltd. | Ferrous Metals | Domestic Equities | 1.67% |
| Manipal Health Enterprises Ltd. | Healthcare Services | Domestic Equities | 1.59% |
| Bosch Ltd. | Auto Components | Domestic Equities | 1.59% |
| Shiprocket Ltd. | Transport Services | Domestic Equities | 1.56% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.36% |
| Total | 100.00% | ||
Mr. Varun Sharma has an impressive career with over 15 years of extensive experience in Investment Management.Mr. Sharma’s professional journey includes significant tenures at esteemed organizations such as ICICI Securities and Franklin Templeton Asset Management Company. Prior to his current role at MOAMC, Mr. Sharma dedicated more than a decade of his expertise to Franklin Templeton, where he excelled as a Fund Manager.
Mr. Ankit Agarwal has an impressive career with over 20 years of investment experience across asset management, portfolio management, equity research, and capital markets. Mr. Agarwal was engaged with UTI AMC, where hegained extensive experience in equity research across healthcare, telecom, technology and midcap sectors. He alsocontributed to Barclays Wealth, providing investment research and insights tailored for highnet-worth clients. Mr. Agarwal’s professional journey includes global exposure through roles at Lehman Brothers (London), BNP Paribas(Hong Kong) and D. E. Shaw (Proprietary trading systems).
Mr. Sandeep Jain is currently employed with MOAMC and has an overall experience of 14 years in research and fund management. His last stint was with Baroda BNP Paribas Mutual Fund as Fund Manager and Senior Research Analyst (BFSI Sector). Prior to that, he has worked with various companies viz., Aditya Birla Sun life Insurance, Sundaram Asset Management Company Limited, TATA Securities., IDBI Capital Markets & Securities Limited. Mr. Jain is a Chartered Accountant by qualification.
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Get personalized portfolio management services designed to grow and protect your wealth.